GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » Additional Paid-In Capital

Insulet (FRA:GOV) Additional Paid-In Capital : €1,028 Mil(As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Insulet Additional Paid-In Capital?


Insulet's quarterly additional paid-in capital declined from Sep. 2023 (€1,013 Mil) to Dec. 2023 (€1,011 Mil) but then increased from Dec. 2023 (€1,011 Mil) to Mar. 2024 (€1,028 Mil).

Insulet's annual additional paid-in capital declined from Dec. 2021 (€1,069 Mil) to Dec. 2022 (€982 Mil) but then increased from Dec. 2022 (€982 Mil) to Dec. 2023 (€1,011 Mil).

Insulet Additional Paid-In Capital Historical Data

The historical data trend for Insulet's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet Additional Paid-In Capital Chart

Insulet Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 674.10 1,039.26 1,068.99 982.33 1,011.08

Insulet Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 978.18 988.26 1,012.99 1,011.08 1,028.19

Insulet Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Insulet Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Insulet's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Insulet (FRA:GOV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » Additional Paid-In Capital
Comparable Companies
BRKR SWAV PEN BIO MASI INSP GMED GKOS ITGR IRTC ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM ZBH ALGN
Traded in Other Exchanges
PODD:USA PODD:Mexico
Address
100 Nagog Park, Acton, MA, USA, 01720
Website
https://www.insulet.com
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.

Insulet (FRA:GOV) Headlines

No Headlines